• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[18F]-THK5351 PET 显像在语义变异型原发性进行性失语症患者中的应用。

[18F]-THK5351 PET Imaging in Patients With Semantic Variant Primary Progressive Aphasia.

机构信息

Departments of Neurology.

Department of Neuroscience, College of Medicine.

出版信息

Alzheimer Dis Assoc Disord. 2018 Jan-Mar;32(1):62-69. doi: 10.1097/WAD.0000000000000216.

DOI:10.1097/WAD.0000000000000216
PMID:29028649
Abstract

BACKGROUND

Semantic variant primary progressive aphasia (svPPA) has been associated with a variety of proteinopathies, mainly transactive response DNA-binding protein, but also with tau and β-amyloid. Recently selective tau tracers for positron emission tomography (PET) have been developed to determine the presence of cerebral tau deposits in vivo. Here, we investigated the topographical distribution of THK5351 in svPPA patients.

MATERIALS AND METHODS

Five svPPA patients, 14 Alzheimer's disease patients, and 15 age-matched normal controls underwent [F]-THK5351 PET scans, magnetic resonance imaging, and detailed neuropsychological tests. [F]-fluorodeoxyglucose PET was obtained in 3 svPPA patients, whereas the remaining 2 underwent amyloid PET using [F]-flutemetamol. Tau distribution among the 3 groups was compared using regions of interest-based and voxel-based statistical analyses.

RESULTS

In svPPA patients, [F]-THK5351 retention was elevated in the anteroinferior and lateral temporal cortices compared with the normal controls group (left>right), and in the left inferior and temporal polar region compared with Alzheimer's disease patients. [F]-THK5351 retention inversely correlated with glucose metabolism, whereas regional THK retention correlated with clinical severity. [F]-flutemetamol scans were negative for β-amyloid.

CONCLUSIONS

These findings show that [F]-THK5351 retention may be detected in cortical regions correlating with svPPA pathology.

摘要

背景

语义变异原发性进行性失语症(svPPA)与多种蛋白病有关,主要是反式作用反应 DNA 结合蛋白,但也与tau 和 β-淀粉样蛋白有关。最近,开发了用于正电子发射断层扫描(PET)的选择性 tau 示踪剂,以确定脑内 tau 沉积物的存在。在这里,我们研究了 THK5351 在 svPPA 患者中的分布情况。

材料和方法

5 名 svPPA 患者、14 名阿尔茨海默病患者和 15 名年龄匹配的正常对照者接受了[F]-THK5351 PET 扫描、磁共振成像和详细的神经心理学测试。3 名 svPPA 患者获得了[F]-氟脱氧葡萄糖 PET,而其余 2 名患者则进行了[F]-flutemetamol 的淀粉样蛋白 PET。使用基于感兴趣区域和基于体素的统计分析比较了 3 组之间的 tau 分布。

结果

在 svPPA 患者中,与正常对照组相比,[F]-THK5351 在前后颞叶皮质(左侧>右侧)和左侧颞极区的保留增加,与阿尔茨海默病患者相比。[F]-THK5351 保留与葡萄糖代谢呈负相关,而区域 THK 保留与临床严重程度相关。[F]-flutemetamol 扫描对β-淀粉样蛋白呈阴性。

结论

这些发现表明,在与 svPPA 病理学相关的皮质区域可能检测到[F]-THK5351 的保留。

相似文献

1
[18F]-THK5351 PET Imaging in Patients With Semantic Variant Primary Progressive Aphasia.[18F]-THK5351 PET 显像在语义变异型原发性进行性失语症患者中的应用。
Alzheimer Dis Assoc Disord. 2018 Jan-Mar;32(1):62-69. doi: 10.1097/WAD.0000000000000216.
2
[F]THK-5351 PET imaging in early-stage semantic variant primary progressive aphasia: a report of two cases and a literature review.[F]早期语义变异型原发性进行性失语的THK-5351正电子发射断层显像:两例报告及文献综述
BMC Neurol. 2018 Aug 8;18(1):109. doi: 10.1186/s12883-018-1115-3.
3
Tau positron emission tomography using [F]THK5351 and cerebral glucose hypometabolism in Alzheimer's disease.使用[F]THK5351的Tau正电子发射断层扫描与阿尔茨海默病中的脑葡萄糖代谢减退
Neurobiol Aging. 2017 Nov;59:210-219. doi: 10.1016/j.neurobiolaging.2017.08.008. Epub 2017 Aug 12.
4
Distinct [F]THK5351 binding patterns in primary progressive aphasia variants.原发性进行性失语症变异中存在不同的 [F]THK5351 结合模式。
Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2342-2357. doi: 10.1007/s00259-018-4075-3. Epub 2018 Jun 26.
5
Relationships between [¹⁸F]-THK5351 Retention and Language Functions in Primary Progressive Aphasia.原发性进行性失语症中[¹⁸F]-THK5351滞留与语言功能的关系
J Clin Neurol. 2019 Oct;15(4):527-536. doi: 10.3988/jcn.2019.15.4.527.
6
Head to head comparison of [F] AV-1451 and [F] THK5351 for tau imaging in Alzheimer's disease and frontotemporal dementia.比较 [F] AV-1451 和 [F] THK5351 在阿尔茨海默病和额颞叶痴呆中的 tau 成像。
Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):432-442. doi: 10.1007/s00259-017-3876-0. Epub 2017 Nov 16.
7
Monoamine oxidase B inhibitor, selegiline, reduces F-THK5351 uptake in the human brain.单胺氧化酶B抑制剂司来吉兰可降低人脑中F-THK5351的摄取。
Alzheimers Res Ther. 2017 Mar 31;9(1):25. doi: 10.1186/s13195-017-0253-y.
8
Neuroimaging-pathological correlations of [F]THK5351 PET in progressive supranuclear palsy.[F]THK5351 PET 神经影像学-病理学相关性在进行性核上性麻痹中的研究。
Acta Neuropathol Commun. 2018 Jun 29;6(1):53. doi: 10.1186/s40478-018-0556-7.
9
Patterns of Distribution of 18F-THK5351 Positron Emission Tomography in Alzheimer's Disease Continuum.阿尔茨海默病连续体中 18F-THK5351 正电子发射断层扫描的分布模式。
J Alzheimers Dis. 2022;85(1):223-234. doi: 10.3233/JAD-215024.
10
Dual tracer tau PET imaging reveals different molecular targets for C-THK5351 and C-PBB3 in the Alzheimer brain.双示踪剂 tau PET 成像显示 C-THK5351 和 C-PBB3 在阿尔茨海默病大脑中针对不同的分子靶点。
Eur J Nucl Med Mol Imaging. 2018 Jul;45(9):1605-1617. doi: 10.1007/s00259-018-4012-5. Epub 2018 May 12.

引用本文的文献

1
[F]RO948 tau positron emission tomography in genetic and sporadic frontotemporal dementia syndromes.[F]RO948 tau 正电子发射断层扫描在遗传性和散发性额颞叶痴呆综合征中的应用。
Eur J Nucl Med Mol Imaging. 2023 Apr;50(5):1371-1383. doi: 10.1007/s00259-022-06065-4. Epub 2022 Dec 14.
2
A Memorial Tribute to Kyoung-Min Lee: An Outstanding Behavioral Neurologist and Cognitive Neuroscientist.向李京敏致敬:一位杰出的行为神经学家和认知神经科学家。
J Clin Neurol. 2022 Nov;18(6):603-609. doi: 10.3988/jcn.2022.18.6.603.
3
Dissecting the Many Faces of Frontotemporal Dementia: An Imaging Perspective.
剖析额颞叶痴呆的多面性:影像学视角。
Int J Mol Sci. 2022 Oct 25;23(21):12867. doi: 10.3390/ijms232112867.
4
Imaging of Reactive Astrogliosis by Positron Emission Tomography.正电子发射断层扫描对反应性星形胶质细胞增生的成像
Front Neurosci. 2022 Feb 8;16:807435. doi: 10.3389/fnins.2022.807435. eCollection 2022.
5
Clinical validity of increased cortical binding of tau ligands of the THK family and PBB3 on PET as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework.在结构化的 5 阶段开发框架背景下,THK 家族和 PBB3 皮质 Tau 配体 PET 增加作为阿尔茨海默病生物标志物的临床有效性。
Eur J Nucl Med Mol Imaging. 2021 Jul;48(7):2086-2096. doi: 10.1007/s00259-021-05277-4. Epub 2021 Mar 15.
6
Multiparametric magnetic resonance imaging and positron emission tomography findings in neurodegenerative diseases: Current status and future directions.多参数磁共振成像和正电子发射断层扫描在神经退行性疾病中的研究进展:现状与未来方向。
Neuroradiol J. 2021 Aug;34(4):263-288. doi: 10.1177/1971400921998968. Epub 2021 Mar 5.
7
Effects of Alzheimer's and Vascular Pathologies on Structural Connectivity in Early- and Late-Onset Alzheimer's Disease.阿尔茨海默病和血管病变对早发型及晚发型阿尔茨海默病结构连接性的影响
Front Neurosci. 2021 Feb 16;15:606600. doi: 10.3389/fnins.2021.606600. eCollection 2021.
8
Identification of Heterogeneous Subtypes of Mild Cognitive Impairment Using Cluster Analyses Based on PET Imaging of Tau and Astrogliosis.基于tau蛋白和星形胶质细胞增生的PET成像,利用聚类分析识别轻度认知障碍的异质性亚型。
Front Aging Neurosci. 2021 Jan 26;12:615467. doi: 10.3389/fnagi.2020.615467. eCollection 2020.
9
Association of Subcortical Structural Shapes With Tau, Amyloid, and Cortical Atrophy in Early-Onset and Late-Onset Alzheimer's Disease.早发型和晚发型阿尔茨海默病中皮质下结构形状与 Tau、淀粉样蛋白及皮质萎缩的关联
Front Aging Neurosci. 2020 Oct 26;12:563559. doi: 10.3389/fnagi.2020.563559. eCollection 2020.
10
Heterozygous Mutation in Semantic Variant of Primary Progressive Aphasia.原发性进行性失语语义变异型中的杂合突变。
J Clin Neurol. 2020 Apr;16(2):352-354. doi: 10.3988/jcn.2020.16.2.352.